PRV being the most efficient strain in colonizing TG. When groups of pigs representing different levels of precolonization of TG with an attenuated PRV strain were challenged with WT PRV, it became evident that there is a statistically significant inverse correlation between the extent of precolonization attained by an attenuated PRV strain in TG and the level of establishment of latency by superinfecting WT PRV. The protection against WT PRV latency did not correlate with the extent of WE PRV replication at the portal of entry.
A common characteristic of all members of the subfamily Alphaherpesvirinae, including pseudorabies virus (PRV), is the ability to establish latency in sensory neurons following an acute infection (27) . In the latent state, the virus does not produce clinical symptoms but it persists indefinitely in the infected individual (9, 25, 27) . After specific stimulation, the latent virus can be reactivated and shed to the environment, thus infecting susceptible individuals (1, 9, 18, 25) . In some cases, it can also produce recrudescence of clinical disease (9, 25, 27) . Latency is, then, very important from an epidemiological standpoint because it is the mechanism by which alphaherpesviruses persist in populations of susceptible individuals (1, 25, 27) .
Protection against the latent state of alphaherpesvirus infection has always been a major goal for the development of specific vaccines (15, 26) . For PRV, classically attenuated or genetically engineered, modified live vaccines have been used successfully for many years to minimize both clinical symptoms and viral shedding during the acute phase of the infection (33) . However, little is known about their influence on the latent phase of the infection (1, 18, 33) .
In studies using animal models of herpes simplex virus infections, it has been reported that the establishment of latency in a target tissue by a preceding viral strain precludes the colonization of the same tissue by another strain (3, 10, 16, 32) . Epidemiological studies of human infections have suggested that this restriction also exists under natural conditions (13) . Subsequently, it was reported that this restriction would not be absolute for herpes simplex virus (11) or bovine herpesvirus 1 (35) . Even attenuated alphaherpesvirus strains could significantly reduce WT virus latency (9) . We developed a quantitative and differential PRV-specific PCR (29) . Using this technique, we show in this report that there is a range of variability among PRV strains in the ability to precolonize trigeminal ganglia (TG) and that a significant correlation exists between the level of latency established by a vaccine strain and the level of protection from latency established by superinfecting WT virus.
For the quantitation of DNA in TG, the entire left and right TG of each animal were combined and processed for total DNA extraction as previously described (5) . The quantitative PCR technique has been described elsewhere (29) The PCR-amplified products were electrophoresed and analyzed by Southern blot hybridization. The amount of radioactivity hybridized to virus-specific and standard-specific amplified products was evaluated by using an Ambys image analyzer. A titration in which logarithmic dilutions of viral DNA were added to a constant amount of PRV-free pig brain DNA was run in parallel for each experiment. The log of the radioactivity hybridized to the amplified viral target/radioactivity hybridized to the amplified standard ratio was plotted against the log of the number of viral copies per cell equivalent. To Only the animals inoculated with WT PRV (Becker strain) exhibited frank clinical disease, and four of them died with clear symptoms of pseudorabies during the acute period of the infection. Ten of the 11 surviving animals were randomly selected for quantitative evaluation of PRV DNA. The pigs in the four groups were killed 37 to 43 days postinfection, and the TG were collected and immediately frozen at -70°C.
The efficiency of colonization was found to be both dose and strain dependent. As shown in Fig. 1 , the tested vaccine strains were less efficient in colonizing TG than was the WT PRV Becker strain, which was able to establish colonization above 10-1.8 viral copies per cell equivalent (1 viral genome copy every 400 cell equivalents) in all of the pigs (Fig. 1 present in these samples was titrated by standard microtitration methods by using Reed and Muench interpolation. Clinical observation was performed daily. The three groups were killed 37 to 40 days after challenge (about 85 days after vaccination), serum samples were collected at the time of killing, and the TG samples were processed as described for the groups used in the first experiment. Figure 2 shows the frequency distribution of the levels of latency attained by the challenging WT virus for each group, compared, in each case, with the levels of precolonization attained by the vaccine strain and doses used for each group as determined in the previous experiment (Fig. 1) . A statistically significant inverse correlation (Pearson's r = -0.577; P < 0.0001) between the levels of latency attained by each of the precolonizing vaccine and WT strains was found for the three groups. In 6 of the 10 pigs vaccinated with 107 TCID50 of the Bartha strain (the best-colonizing strain), no WT viral DNA could be detected (limit of sensitivity, approximately one viral genome per 5 x 106 cell equivalents) ( Fig. 2A) the frequency distribution for WT virus latency levels in this group is bimodal, which correlates with the bimodal distribution also seen for the level of latency established by the precolonizing vaccine strain ( Fig. 1 and 2A (Fig. 2B ).
In this case, the frequency distribution of the level of latency was approximately normal, with the peak in the medium range, for both WT and vaccine strains ( Fig. 1 and 2B (29) ; therefore, if differences in colonization indeed exist between these two groups, they would go undetected. In summary, it can be stated that for each log unit of increase in the attenuated-strain precolonization level in TG, there was a 1.076-log-unit decrease in the level of WT PRV latency attained in that tissue (r = -0.577; P < 0.0001, regression F2,28 = 14.0). The levels of neutralizing antibodies, as determined by a standard protocol (6) , are shown in Table 2 . Because of significant within-group variability, differences in the neutralizing antibody titers observed among the three groups, after precolonization and prior to WT PRV challenge, were not significant (F2,21 = 2.566; P -0.1). When two-way ANOVA =0.8484; P> 0.1).
The shedding of WT PRV after challenge of the three differently precolonized groups was quantitated by taking conjunctival and pharyngeal swab samples of all challenged animals at 3, 5, 7, 9, and 11 days postchallenge. As shown in Fig. 3 , there were no statistically significant differences (Fisher's test [31] ) in either the amounts or the lengths of time of viral shedding among the three treatment groups. In all cases, differences within each group were larger than those between groups. Daily clinical evaluation of the animals indicated no significant clinical differences among the three groups following the challenge. All of the animals in the three groups were well protected in comparison with the nonvaccinated group that received an identical dose of WT PRV (Becker strain) (group IV, experiment 1) (Fig. 1) (Fig. 3) (31) .
were completely protected from WT latency ( Fig. 2A; group BA, 107 TCID5O) was the one that shed the largest amount of virus after challenge in this group. Furthermore, in analyzing animal-by-animal viral shedding and the corresponding level of latency established by the superinfecting WT PRV, no correlation was evident between these two parameters (r = -0.1359; P = 0.503) (Fig. 4) . In addition, we did not observe significant clinical differences among the three groups during the early postchallenge period, as all of the animals from the three groups were fairly well protected. Therefore, although a direct immunological modulation of the establishment of WT PRV latency cannot be ruled out by these experiments, impairment of replication at the portal of entry does not seem to explain the differences observed in levels of colonization of TG by WT PRV. If the differences in establishment of WT PRV latency are not based on differences in WT PRV replication at the primary site of replication, it is conceivable that the blocking of WT PRV establishment takes place at the translocation (axonal path) or neuronal level instead. The protection against WT latency observed in our experiments could be an example of resistance at the level of the tissues that are the target for latency, for which preinfection of the neurons of that tissue with another (preceding) strain of PRV is required. The case of ganglionar resistance we observed would then be a special example of intracellular interference active against homologous or homotypic viruses (24) . It is possible that the interference is based on some of the viral functions (especially LAT gene activity) expressed by the interfering strain during latency or reactivation (4, 22, 23, 25) or on some competition for certain important cellular factors that would be essential to the establishment and/or maintenance of neuronal latent infection (12) . The apparent occurrence of a certain threshold for latency (which could be defined by the fact that the observed frequency of establishment of latency above 10' Fig. 1 and 2] ) would be consistent with the models that propose that only a subset of TG neurons are capable of harboring a latent infection (14) . Under these conditions, once this susceptible subset of cells has been latently infected by the preceding vaccine strain, they cannot be superinfected with the WT challenging virus. Another plausible explanation for the interference with WT PRV colonization could be based on direct involvement of the immune response at the level of the site of colonization, in this case, the TG. Further studies should certainly be directed towards addressing these points.
In this study, we have found that there is a significant inverse correlation between the level of latency established by an alphaherpesvirus live modified vaccine and the level of latency established by a superinfecting WT virus in the natural host of the infection. Therefore, modified live virus vaccines administered through routes of immunization that maximize colonization of latency target tissues may significantly decrease latency of WT strains. The different genetic deletions of the strains which we used have certainly influenced the different colonization abilities observed in our experiments. It has been reported that PRV gI is an important factor in targeting the virus to the central nervous system (2, 34) and also that thymidine kinase is important for herpesvirus replication in quiescent cells (i.e., neurons) (7, 21) . The simultaneous deletion of the genes encoding both these factors in strain SG should then have impaired both targeting of the virus to neurons and viral replication in neurons, therefore explaining the poor colonization of TG observed with this strain. It is interesting that colonization studies conducted in our laboratory with a gI+ strain isogeneic to SG (strain SMB; Syntrovet) (data not shown) showed that this strain has colonization ability significantly greater than that of any of the strain-dose combinations reported in this paper, thus not only confirming the important role of PRV gI in targeting neural tissue but also suggesting that gI+ attenuated PRV strains may have optimal ability to precolonize TG and therefore to interfere with superinfecting WT latency. Considering the results herein reported, the ability of a vaccine to establish latency by itself would then be a subject worth pursuing.
